For the first time in the world, a device, developed by Sharp Corporation, equipped with Plasmacluster technology, which ...

Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...

In a comparison of COVID-19 vaccines, the mRNA vaccine sustained higher anti-S IgG, while the Ad-vector had superior neutralizing capacity.

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...

Since the start of the COVID-19 pandemic, there has been controversy surrounding the origins of SARS-CoV-2. New research from the University of California, San Diego (UCSD), School of Medicine ...

In a recent review published in the journal Cell Communication and Signaling, a team of researchers in Egypt and the United States explored the direct and indirect mechanisms of T lymphocyte-linked ...

Llama antibodies clamp the coronavirus shut at its weakest spot—leaving the virus powerless to mutate or infect.

The question of the origin of SARS-CoV-2 continues to occupy scientists, the media, and the public intensely even 5 years after the onset of the COVID-19 pandemic. Where the virus came from, when and ...

During the first few years of the COVID-19 pandemic, the virus SARS-CoV-2 was detected in an increasing number of non-human animal species. This included many wild animal species as well as domestic ...

In a recent study published in the International Journal of Environmental Research and Public Health, researchers in the United States (U.S.) conducted a systematic review to determine the factors ...